Dunn A - Search Results

1

Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database study.

Kumar R, Stanek J, Creary S, Dunn A, O'Brien SH. Kumar R, et al. Among authors: dunn a. Blood Adv. 2018 Feb 13;2(3):285-291. doi: 10.1182/bloodadvances.2017012336. Blood Adv. 2018. PMID: 29431623 Free PMC article.

2

Changing Paradigm of Hemophilia Management: Extended Half-Life Factor Concentrates and Gene Therapy.

Kumar R, Dunn A, Carcao M. Kumar R, et al. Among authors: dunn a. Semin Thromb Hemost. 2016 Feb;42(1):18-29. doi: 10.1055/s-0035-1568877. Epub 2016 Jan 15. Semin Thromb Hemost. 2016. PMID: 26771678 Review.

3

Activated Partial Thromboplastin Time versus Anti-Factor Xa Levels for Monitoring Unfractionated Heparin Therapy in Children: An Institutional Experience.

Woods GM, Stanek J, Harrison S, Texter K, Kerlin BA, Dunn AL, Kumar R. Woods GM, et al. Among authors: dunn al. J Pediatr Hematol Oncol. 2017 Oct;39(7):576-577. doi: 10.1097/MPH.0000000000000966. J Pediatr Hematol Oncol. 2017. PMID: 28902081 No abstract available.

4

Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study.

Woods GM, Sharma R, Creary S, O'Brien S, Stanek J, Hor K, Young J, Dunn AL, Kumar R. Woods GM, et al. J Pediatr. 2018 Jun;197:186-190.e1. doi: 10.1016/j.jpeds.2018.01.073. Epub 2018 Mar 28. J Pediatr. 2018. PMID: 29605397

5

Inpatient Health Care Utilization in Children With Hemophilia Before and After the Joint Outcome Study Publication.

Drayton Jackson M, O'Brien SH, Stanek J, Dunn AL, Kerlin BA. Drayton Jackson M, et al. Among authors: dunn al. J Pediatr Hematol Oncol. 2019 Jul;41(5):e284-e289. doi: 10.1097/MPH.0000000000001329. J Pediatr Hematol Oncol. 2019. PMID: 30339654

6

Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study.

Sharma R, Woods GM, Creary S, O'Brien S, Stanek J, Hor K, Gallagher C, Dunn AL, Kumar R. Sharma R, et al. Pediatr Blood Cancer. 2019 Apr;66(4):e27588. doi: 10.1002/pbc.27588. Epub 2018 Dec 13. Pediatr Blood Cancer. 2019. PMID: 30548773

7

A Novel Clinician-Orchestrated Virtual Reality Platform for Distraction During Pediatric Intravenous Procedures in Children With Hemophilia: Randomized Controlled Trial.

Dunn A, Patterson J, Biega CF, Grishchenko A, Luna J, Stanek JR, Strouse R. Dunn A, et al. JMIR Serious Games. 2019 Jan 9;7(1):e10902. doi: 10.2196/10902. JMIR Serious Games. 2019. PMID: 30626567 Free PMC article.

8

Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort.

Saini S, Folta AN, Harsh KL, Stanek JR, Dunn AL, O'Brien SH, Kumar R. Saini S, et al. J Pediatr. 2019 Jun;209:212-219.e1. doi: 10.1016/j.jpeds.2019.02.015. Epub 2019 Apr 5. J Pediatr. 2019. PMID: 30961988

9

Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male.

Kumar R, Dawson J, Varga E, Canini JT, Monda KL, Dunn AL. Kumar R, et al. Pediatr Blood Cancer. 2019 Sep;66(9):e27832. doi: 10.1002/pbc.27832. Epub 2019 May 27. Pediatr Blood Cancer. 2019. PMID: 31131962

10

Screening urinalysis demonstrates that haematuria is a frequent finding in persons with haemophilia treated at a paediatric haemophilia treatment centre.

Davis KA, Stanek JR, Dunn AL. Davis KA, et al. Among authors: dunn al. Haemophilia. 2019 Sep;25(5):782-788. doi: 10.1111/hae.13815. Epub 2019 Jul 10. Haemophilia. 2019. PMID: 31291048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,001 results

Search Page

Filters